204 related articles for article (PubMed ID: 7489307)
21. [Differentiation between benign and malignant breast lesions using fat-suppressed dynamic MR imaging].
Koshiishi T; Isomoto I; Nakamura K; Kajiwara Y; Izawa K
Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Jul; 58(8):433-40. PubMed ID: 9745257
[TBL] [Abstract][Full Text] [Related]
22. [Technics for the preoperative marking of nonpalpable breast lesions in MRT].
Sittek H; Kessler M; Müller-Lisse U; Untch M; Bohmert H; Reiser M
Rofo; 1996 Jul; 165(1):84-7. PubMed ID: 8765369
[TBL] [Abstract][Full Text] [Related]
23. [Dynamic 3D MR mammography using a rapid gradient-echo sequence].
Müller-Schimpfle M; Rieber A; Kurz S; Stern W; Claussen CD
Rofo; 1995 Jan; 162(1):13-9. PubMed ID: 7841394
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of time-intensity curves in ductal carcinoma in situ (DCIS) and mastopathy obtained using dynamic contrast-enhanced magnetic resonance imaging.
Nishiura M; Yasuhiro T; Murase K
Magn Reson Imaging; 2011 Jan; 29(1):99-105. PubMed ID: 20833496
[TBL] [Abstract][Full Text] [Related]
25. Invasive breast carcinoma: analysis of dynamic magnetic resonance imaging enhancement features and cell proliferative activity determined by DNA S-phase percentage.
Stomper PC; Herman S; Klippenstein DL; Winston JS; Budnick RM; Stewart CC
Cancer; 1996 May; 77(9):1844-9. PubMed ID: 8646683
[TBL] [Abstract][Full Text] [Related]
26. [Diagnostic value of ADC and rADC of diffusion weighted imaging in malignant breast lesions].
Xie CM; Yin SH; Li H; Liu XW; Zhang Y; Lü YC; Zhang R; Li JP; Geng ZJ; Wu PH
Zhonghua Zhong Liu Za Zhi; 2010 Mar; 32(3):217-20. PubMed ID: 20450592
[TBL] [Abstract][Full Text] [Related]
27. [MR mammography in patients at risk].
Kaiser WA; Mittelmeier O
Rofo; 1992 Jun; 156(6):576-81. PubMed ID: 1617179
[TBL] [Abstract][Full Text] [Related]
28. [MR mammography at 0.5 tesla. II. The capacity to differentiate malignant and benign lesions in MR mammography at 0.5 and 1.5 T].
Kuhl CK; Kreft BP; Hauswirth A; Gieseke J; Elevelt A; Reiser M; Schild HH
Rofo; 1995 Jun; 162(6):482-91. PubMed ID: 7605960
[TBL] [Abstract][Full Text] [Related]
29. [The marking of nonpalpable breast tumors in MRT].
Schmitt R; Helmberger T; Fellner F; Obletter N
Rofo; 1993 Nov; 159(5):484-6. PubMed ID: 8219146
[No Abstract] [Full Text] [Related]
30. [Contrast enhancement of the nipple in nuclear magnetic resonance tomography of the breast with Gd-DTPA].
Beck R; Heywang SH; Eiermann W; Permanetter W; Lissner J
Digitale Bilddiagn; 1987 Dec; 7(4):167-9. PubMed ID: 3436118
[TBL] [Abstract][Full Text] [Related]
31. Clinical MR mammography: impact of hormonal status on background enhancement and diagnostic accuracy.
Baltzer PA; Dietzel M; Vag T; Burmeister H; Gajda M; Camara O; Pfleiderer SO; Kaiser WA
Rofo; 2011 May; 183(5):441-7. PubMed ID: 21318935
[TBL] [Abstract][Full Text] [Related]
32. Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with pharmacokinetic analysis of gadolinium-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma.
Mussurakis S; Buckley DL; Bowsley SJ; Carleton PJ; Fox JN; Turnbull LW; Horsman A
Invest Radiol; 1995 Nov; 30(11):650-62. PubMed ID: 8557506
[TBL] [Abstract][Full Text] [Related]
33. [Magnetic resonance tomography of the breast. The results of 253 examinations].
Kaiser WA
Dtsch Med Wochenschr; 1989 Sep; 114(36):1351-7. PubMed ID: 2776660
[TBL] [Abstract][Full Text] [Related]
34. [Diagnostic value of preoperative contrast-enhanced MR imaging of the breast].
Winnekendonk G; Krug B; Warm M; Göhring UJ; Mallmann P; Lackner K
Rofo; 2004 May; 176(5):688-93. PubMed ID: 15122467
[TBL] [Abstract][Full Text] [Related]
35. [Contrast media in MR mammography].
Tontsch P; Bauer M; Birmelin G; von Landenberg E; Moeller TB; Raible G
Aktuelle Radiol; 1997 Mar; 7(2):86-92. PubMed ID: 9172669
[TBL] [Abstract][Full Text] [Related]
36. MR imaging of the breast with Gd-DTPA: use and limitations.
Heywang SH; Wolf A; Pruss E; Hilbertz T; Eiermann W; Permanetter W
Radiology; 1989 Apr; 171(1):95-103. PubMed ID: 2648479
[TBL] [Abstract][Full Text] [Related]
37. CE-Magnetic Resonance Mammography for the evaluation of the contralateral breast in patients with diagnosed breast cancer.
Pediconi F; Venditti F; Padula S; Roselli A; Moriconi E; Giacomelli L; Catalano C; Passariello R
Radiol Med; 2005; 110(1-2):61-8. PubMed ID: 16163140
[TBL] [Abstract][Full Text] [Related]
38. Potential of MR mammography to predict tumor grading of invasive breast cancer.
Dietzel M; Baltzer PA; Vag T; Zoubi R; Gröschel T; Burmeister H; Gajda M; Runnebaum IB; Kaiser WA
Rofo; 2011 Sep; 183(9):826-33. PubMed ID: 21442559
[TBL] [Abstract][Full Text] [Related]
39. Breast lesion localization: a freehand, interactive MR imaging-guided technique.
Daniel BL; Birdwell RL; Ikeda DM; Jeffrey SS; Black JW; Block WF; Sawyer-Glover AM; Glover GH; Herfkens RJ
Radiology; 1998 May; 207(2):455-63. PubMed ID: 9577495
[TBL] [Abstract][Full Text] [Related]
40. [A prototype double coil for MR breast measurement].
Kaiser WA; Kess H
Rofo; 1989 Jul; 151(1):103-5. PubMed ID: 2546196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
